State Street’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.4M Buy
671,112
+234,965
+54% +$5.54M ﹤0.01% 2452
2025
Q4
$11.6M Buy
436,147
+160,022
+58% +$4.12M ﹤0.01% 2574
2025
Q3
$6.56M Buy
276,125
+142,691
+107% +$2.55M ﹤0.01% 2873
2025
Q2
$2.21M Buy
+133,434
New +$2.91M ﹤0.01% 3276

Other funds holding KMTS

State Street's KMTS Position: Q1 2026 in Review

State Street increased its Kestra Medical Technologies (KMTS) stake by 54% in Q1 2026, buying an estimated $5.54M and bringing the position to 671,112 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2452.

State Street first reported a position in KMTS in Q2 2025 and has held it in 4 quarters since. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • State Street held 671,112 shares of Kestra Medical Technologies worth $13.4M as of Q1 2026.
  • State Street bought 234,965 Kestra Medical Technologies shares in Q1 2026, an estimated $5.54M.
  • Kestra Medical Technologies made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2452 holding.
  • State Street first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 4 quarters since.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.